📰 Trepl News
Page 5 - Trepl News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Trepl. Real-time updates on events, politics, business and more.
May 19, 2023
Replimune Group, Inc. (NASDAQ:REPL – Get Rating) insider Sushil Patel sold 15,575 shares of the company’s stock in a transaction dated Tuesday, May 16th. The stock was sold at an average price of $18.05, for a total value of $281,128.75. Following the sale, the insider now owns 154,571 shares in the company, valued at approximately […]
May 19, 2023
Replimune Group, Inc. (NASDAQ:REPL – Get Rating) insider Sushil Patel sold 15,575 shares of the stock in a transaction that occurred on Tuesday, May 16th. The stock was sold at an average price of $18.05, for a total value of $281,128.75. Following the completion of the transaction, the insider now directly owns 154,571 shares of […]
May 19, 2023
Letko Brosseau & Associates Inc. cut its holdings in Replimune Group, Inc. (NASDAQ:REPL – Get Rating) by 67.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 7,525 shares of the company’s stock after selling 15,275 shares during the period. […]
April 29, 2023
Shares of Replimune Group, Inc. (NASDAQ:REPL – Get Rating) have received an average recommendation of “Buy” from the six research firms that are currently covering the firm, MarketBeat reports. Six research analysts have rated the stock with a buy recommendation. The average twelve-month target price among analysts that have updated their coverage on the stock […]
April 21, 2023
Piper Sandler restated their overweight rating on shares of Replimune Group (NASDAQ:REPL – Get Rating) in a research note published on Monday morning, Benzinga reports. The firm currently has a $44.00 target price on the stock. A number of other brokerages have also commented on REPL. HC Wainwright boosted their price objective on Replimune Group […]
April 4, 2023
Replimune Group, Inc. (NASDAQ:REPL – Get Rating) has been given an average recommendation of “Buy” by the seven research firms that are currently covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokers that have updated their coverage on the stock […]
April 4, 2023
Replimune Group, Inc. (NASDAQ:REPL – Get Rating) has been given an average recommendation of “Buy” by the seven research firms that are currently covering the firm, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy recommendation. The average twelve-month price target among brokers that have updated their coverage on the stock […]
April 2, 2023
Shares of Replimune Group, Inc. (NASDAQ:REPL – Get Rating) have been assigned an average recommendation of “Buy” from the seven ratings firms that are covering the stock, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12-month target price among brokers that have issued a report on the […]
March 31, 2023
The GIS-based master/ development plans will provide the basis for infrastructure provision, effective land use and utilisation, spatial growth management, enable project planning and urban management to the development authorities